Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis extract for symptoms of Alzheimer's disease in elderly patients
RBR-103jtq75Phase 2Recruiting
- Sponsor
- Faculdade de Medicina de Jundiaí
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cannabidiol and dronabinol in Alzheimer's disease (AD) (2 arms), sponsored by Faculdade de Medicina de Jundiaí. Started Jul 2025; status: recruiting.
02
Drugs
cannabidioldronabinol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on RBR-103jtq75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-103jtq75.